Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurotropin for repair of spinal cord injury
ChiCTR2000039305Phase 4Recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Nov 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vaccinia virus-inoculated rabbit skin extract in spinal cord injury (SCI) (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoints: ASIA spinal cord injury score, Neuroelectrophysiological examination and 2 more. Started Nov 2020; status: recruiting.
02
Drugs
vaccinia virus-inoculated rabbit skin extract
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on ChiCTR2000039305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039305.